Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07518446
What this trial is testing

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

Who this might be right for
Atrial Fibrillation (AF)Heart FailureAsthma (Diagnosis)+4 more
Amager Hospital 2,800
Testing effectiveness (Phase 2)Ended earlyNCT05860296
What this trial is testing

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage IVLung Cancer Metastatic
SignalChem Lifesciences Corporation 36
Early research (Phase 1)Active Not RecruitingNCT04503278
What this trial is testing

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

Who this might be right for
Solid Tumor
BioNTech Cell & Gene Therapies GmbH 214
Testing effectiveness (Phase 2)Looking for participantsNCT07405151
What this trial is testing

A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)Study completedNCT04305054
What this trial is testing

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 335
Not applicableStudy completedNCT04241796
What this trial is testing

Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice

Who this might be right for
Cancer
GRAIL, Inc. 6,662
Testing effectiveness (Phase 2)Ended earlyNCT00373204
What this trial is testing

Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)

Who this might be right for
Lung Cancer
Pharmacyclics LLC. 50
Early research (Phase 1)Study completedNCT03312426
What this trial is testing

An Investigational Study to Assess the Effect of a Light Meal and a High-Fat Meal on the Absorption of BMS-986205 in Healthy Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)UnknownNCT05296772
What this trial is testing

Phase 1 First-in-human Study of JS014

Who this might be right for
Neoplasm MalignantNeoplasm, ExperimentalSolid Tumor, Adult+1 more
Anwita Biosciences 60
Large-scale testing (Phase 3)Looking for participantsNCT07028853
What this trial is testing

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Hormone Sensitive Prostate CancerProstate Cancer+1 more
Pfizer 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02641782
What this trial is testing

NB2013-HR German (GPOH) / Dutch (DCOG) Trial

Who this might be right for
Neuroblastoma
University of Cologne 3
Large-scale testing (Phase 3)Study completedNCT00932893
What this trial is testing

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 347
Large-scale testing (Phase 3)Study completedNCT04164199
What this trial is testing

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

Who this might be right for
Advanced Malignancies
BeOne Medicines 404
Not applicableStudy completedNCT07348900
What this trial is testing

Effect of Recreational Play Activities on Anxiety in Children Receiving Chemotherapy and Their Parents

Who this might be right for
AnxietyPain
Akdeniz University 64
Not applicableEnded earlyNCT01243333
What this trial is testing

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm
University of Utah 26
Very early researchStudy completedNCT00972933
What this trial is testing

Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma

Who this might be right for
Melanoma
Diwakar Davar 59
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Not applicableActive Not RecruitingNCT05708599
What this trial is testing

Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaColorectal CancerPancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 102
Testing effectiveness (Phase 2)Study completedNCT02488759
What this trial is testing

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 578
Testing effectiveness (Phase 2)UnknownNCT04469127
What this trial is testing

A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.

Who this might be right for
Breast Cancer Stage IV
Advanced Imaging Projects, LLC 100
Next Page